Abstract:figure legend A significant proportion of adults and adolescents regularly sleep less than recommended by the Sleep Research Society and American Academy of Sleep Medicine, which is associated with adverse cardiometabolic risk. One hypothesized strategy to combat such risk is to increase or extend nightly sleep duration. This topical review highlights potential mechanisms linking short sleep duration with adverse cardiometabolic risk and summarizes current evidence on potential cardiometabolic health benefits of sleep extension. Given that many unanswered questions remain, we conclude by outlining future research directions and suggesting best practices to help advance our understanding of sleep extension as an intervention to improve cardiometabolic health. Abbreviation: RCTs, randomized controlled trials. (Created with BioRender.com). Short sleep duration is associated with heightened cardiometabolic disease risk and has reached epidemic proportions among children, adolescents and adults. Potential mechanisms underlying this association are complex and multifaceted, including disturbances in circadian timing, food intake and appetitive hormones, brain regions linked to control of hedonic eating, physical activity, an altered microbiome and impaired insulin sensitivity. Sleep extension, or increasing total sleep duration, is an emerging and ecologically relevant intervention with significant potential to advance our understanding of the mechanisms underlying the association between short sleep duration and the risk of cardiometabolic disease. If effective, sleep extension interventions have potential to improve cardiometabolic health across the lifespan. Existing data show that sleep extension is feasible and might have potential cardiometabolic health benefits, although there are limitations that the field must overcome. Notably, most existing studies are short term (2–8 weeks), use different sleep extension strategies, analyse a wide array of cardiometabolic health outcomes in different populations and, frequently, lack adequate statistical power, thus limiting robust scientific conclusions. Overcoming these limitations will require fully powered, randomized studies conducted in people with habitual short sleep duration and existing cardiometabolic risk factors. Additionally, randomized controlled trials comparing different sleep extension strategies are essential to determine the most effective interventions. Ongoing and future research should focus on elucidating the potential cardiometabolic health benefits of sleep extension. Such studies have high potential to generate crucial knowledge with potential to improve health and quality of life for those struggling with short sleep duration.

Alterations in lectin binding to guinea pig spermatozoa accompanying in vitro capacitation and the acrosome reaction.

Potential Biochemical Pathways for the Relationship Between Sleep Duration and Mortality.

Sleep extension and cardiometabolic health: what it is, possible mechanisms and real‐world applications

Abstract 10978: Sleep Duration and Risks of Cardiovascular Disease Onset and Mortality among Patients with Type 2 Diabetes

Sleep Extension in Short Sleepers: An Evaluation of Feasibility and Effectiveness for Weight Management and Cardiometabolic Disease Prevention

Sleep Deficiency and Cardiometabolic Disease

Relationship of sleep duration with incident cardiovascular outcomes: a prospective study of 33,883 adults in a general population

Sleep duration irregularity and risk for incident cardiovascular disease in the UK Biobank

Sex-Specific Associations Between Self-reported Sleep Duration, Cardiovascular Disease, Hypertension, and Mortality in an Elderly Population

The association between sleep characteristics and the risk of all-cause mortality among individuals with cardiometabolic multimorbidity: a prospective study of UK Biobank

Associations of Long-term Sleep Duration Trajectories with Overall and Cause-Specific Mortality Among Middle-to-older Aged Black and White Adults

Associations of sleep with cardiometabolic risk factors and cardiovascular diseases: an umbrella review of observational and Mendelian randomization studies

Sleep patterns and risk of chronic disease as measured by long-term monitoring with commercial wearable devices in the All of Us Research Program

Sleep duration and mortality in patients with chronic noncommunicable disease: a population-based cohort study

Causal associations of short and long sleep durations with 12 cardiovascular diseases: linear and nonlinear Mendelian randomization analyses in UK Biobank

Relationship Between Sleep Duration and Cognitive Function in Older Adults: Analysis of NHANES and UK Biobank GWAS Data

Sleep Patterns and Traditional Cardiovascular Health Metrics: Joint Impact on Major Adverse Cardiovascular Events in a Prospective Cohort Study

Associations of Accelerometer-measured Sleep Duration with Incident Cardiovascular Disease and Cardiovascular Mortality

Sleep duration, baseline cardiovascular risk, inflammation and incident cardiovascular mortality in ambulatory U.S. Adults: National health and nutrition examination survey

The impact of daily sleep duration on health: a review of the literature

Association of sleep characteristics with cardiovascular disease risk in adults over 40 years of age: a cross-sectional survey